Topic
Multidistrict Litigation
457 published works
Drug & Device Law
Plaintiffs’ Lead Counsel Off The Hook In Yaz MDL
Multidistrict litigation is not special. By making this pithy observation, we do not mean to denigrate what has become the mother of all procedural mechanisms. What we mean is that…
Drug & Device Law
Sanctions For An MDL Bellwether Plaintiff’s Discovery Conduct
Stop us if you have heard this before. A novel or movie depicts litigation in which a large corporate defendant is sued for causing a plaintiff or plaintiffs significant injuries…
Drug & Device Law
No Take Backs for Lexecon Waivers
Remember the days when saying things like no cutting, no backsies, no do-overs were the laws you lived by. Or when “calling” something actually gave you priority. When invoked, these…
Drug & Device Law
Impressions on Duke Conference on Documenting & Seeking Solutions to Mass-Tort MDL Problems
By Bexis
Bexis has lots of opinions on what’s wrong with mass-tort (especially drug/device) MDLs. Heck, Bexis has even proposed amendments to the MDL statutes to correct the many severe problems that…
Drug & Device Law
When MDL Judges Come To Visit
By Bexis
We wrote a post not too long ago recommending that MDL defendants seriously consider limiting so called “Lexecon (read the prior post if you don’t know what that means) waivers”…
Civil Procedure & Federal Courts Blog
Bradt & Clopton on MDL, Public Law & Trump
Andrew Bradt and Zach Clopton have published their essay, MDL v. Trump: The Puzzle of Public Law in Multidistrict Litigation, 112 Nw. U. L. Rev. 905 (2018). Here’s the abstract:Litigation…
Life Sciences Legal Update
Upcoming Free CLE Webinar: “Multidistrict Litigation: What to Expect from JPML Consolidation Through Trial”
By Lisa Baird
With more than half of all cases pending in the federal courts now docketed in multidistrict litigations (MDLs), pharmaceutical and medical device companies facing large-scale litigation should expect to find…
Drug & Device Law
Only You Can Prevent….
By Bexis
We’ve seen the latest affirmance of largely identical verdicts in a consolidated MDL trial in Campbell v. Boston Scientific Corp., ___ F.3d ___, 2018 WL 732371 (4th Cir. Feb. 6,…
Drug & Device Law
The Lawyer Full Employment Action of 2018
By Bexis
On January 30, 2018, Judge Goodwin entered four case management orders in the Ethicon, Boston Scientific, Bard, and American Medical Systems mesh MDLS. These CMOs establish discovery and briefing deadlines…
Drug & Device Law
Post-Remand Consolidated Mesh Trial Upheld on Appeal
This post is from the non-Reed Smith side of the blog. Looking back on the blog, the last time we posted about the Pelvic Mesh MDL was this summer when…